Overview

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Study to show the safety, tolerability and preliminary effectiveness of Intradiscal rhGDF-5 in subjects with early lumbar disc degeneration
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
DePuy Spine
Collaborator:
Janssen Korea, Ltd., Korea